Reposition
JSB-Partners offers specialized investment banking and advisory services to biotechnology and pharmaceutical companies. JSB-Partners works closely with clients to deliver impactful business and corporate development resources and expertise. To meet clients needs, the firm offers strategic analyses, targeted selection of and communications with potential transaction parties, proven negotiation skills, and other services needed to drive transactions to a successful closing. Their exclusive partnership with Noble Financial Capital Markets allows them to deliver a complete range of corporate finance services.
JSB Partners - Recent News & Articles
Guernsey stock exchange now provides a facility for trading shares in privately held companies. A stock exchange based in the Channel Islands is tryin...
ARK Invest founder and CEO Cathie Wood expects that a “changing of the guard” at the United States Securities and Exchange Commission may turbocharge ...
The new research looks at the UK’s banking sector and how it compares to other G8 countries. It notes that as a result of deregulation reforms, stable...
The Impact of Two Consumer Classes and the Fed Funds Rate Outlook
Investing.com -- The Federal Reserve may need to implement more aggressive rate cuts as recent data reveals a concerning trend in the labor market, ac...
For two long years private companies have spurned public markets, as rising interest rates dashed lofty valuations and stock prices vacillated. All th...
The volume of deals worldwide valued at more than $100 million plunged 37% to just 280 during the first half of this year, undercut by rising interest...
Investment bankers’ advisory fees have plunged to the lowest level in almost a decade because of a prolonged slowdown in deal activity. Fees for compl...
SVB Financial Group, the former parent company of Silicon Valley Bank, has entered into an agreement to sell its investment banking business, SVB Secu...
Mizuho Financial Group is forging further into U.S. investment banking through a deal to buy Greenhill & Co. as it seeks to accelerate growth. The Jap...